| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |